Amyloid deposits stain positively with all of the following except?
All lysosomal storage diseases are autosomal recessive, EXCEPT?
Karyotyping of a fetus is done by all the following procedures except?
Which of the following stains can be used to demonstrate fat?
Which of the following is an autoimmune disease mediated by T cells?
What is the most common autoimmune disease in young men?
A patient presents with fatigue, fever, anorexia, and weight loss. What is the most likely diagnosis?
What does dyskeratosis refer to?
Epithelioid granuloma may be seen in all of the following conditions except?
All of the following are angiogenic factors EXCEPT?
Explanation: **Explanation:** Amyloidosis is characterized by the extracellular deposition of misfolded proteins in a cross-beta-pleated sheet configuration [1]. The correct answer is **Methenamine silver** because it is primarily used to stain fungi (e.g., *Pneumocystis jirovecii*) and basement membranes (e.g., in renal pathology), not amyloid. **Analysis of Options:** * **Congo Red (Option A):** This is the gold standard for amyloid. Under ordinary light, it stains amyloid pink-red [1]. Under polarized light, it demonstrates the pathognomonic **apple-green birefringence** [1]. * **Crystal Violet (Option B):** This is a metachromatic stain. Amyloid reacts with the dye to produce a rose-pink or violet color, while the background tissue remains blue. * **Thioflavin T (Option D):** This is a fluorescent stain. When viewed under a fluorescence microscope, amyloid deposits show a secondary yellow-green fluorescence. It is highly sensitive but less specific than Congo Red. **High-Yield Clinical Pearls for NEET-PG:** * **H&E Stain:** Amyloid appears as an amorphous, eosinophilic, extracellular hyaline substance [2]. * **Sirius Red:** Another specific stain that shows birefringence similar to Congo Red. * **Iodine/Sulfuric Acid:** Historically, Virchow used iodine (turning amyloid mahogany brown) followed by sulfuric acid (turning it blue/black), which led to the name "amyloid" (starch-like) [1]. * **Most common type:** AL (Light chain) is associated with Plasma Cell Dyscrasias; AA (Amyloid Associated) is associated with chronic inflammation [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-269. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 533-534.
Explanation: **Explanation:** **Core Concept:** Lysosomal Storage Diseases (LSDs) are a group of inherited metabolic disorders caused by deficiencies in specific lysosomal enzymes [1]. As a general rule in genetics, most enzyme deficiencies follow an **Autosomal Recessive (AR)** inheritance pattern [2]. However, there are two notable exceptions that follow an **X-linked Recessive (XLR)** pattern: **Fabry disease** and **Hunter syndrome** [3]. **Why Option A is Correct:** * **Fabry’s Disease:** It is caused by a deficiency of the enzyme **$\alpha$-galactosidase A**, leading to the accumulation of globotriaosylceramide. Unlike most LSDs, the gene responsible is located on the X chromosome, making its inheritance **X-linked Recessive**. **Why Other Options are Incorrect:** * **B. Hurler Disease (MPS I):** This is the prototypical Mucopolysaccharidosis caused by $\alpha$-L-iduronidase deficiency [4]. It follows the standard **AR** pattern. (Note: Do not confuse this with Hunter syndrome, which is XLR). * **C. Morquio Disease (MPS IV):** Characterized by short stature and skeletal dysplasia, it is inherited in an **AR** fashion. * **D. Gaucher Disease:** The most common LSD (glucocerebrosidase deficiency) follows an **AR** inheritance pattern. **NEET-PG High-Yield Pearls:** 1. **The "X-linked" Rule:** Remember the mnemonic: *"The **Hunter** aims for the **X** (X-linked) and sees clearly (No corneal clouding)."* This helps distinguish Hunter syndrome (XLR) from Hurler syndrome (AR + corneal clouding). 2. **Fabry Clinical Triad:** Episodic peripheral neuropathy (burning pain), angiokeratomas, and hypohidrosis. Late complications include renal and cardiac failure. 3. **Gaucher Cells:** Look for "wrinkled tissue paper" appearance of the cytoplasm in macrophages. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 159-161. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 150-151. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, p. 151. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 163-164.
Explanation: **Explanation:** Karyotyping requires cells that are actively dividing or can be easily stimulated to undergo mitosis in culture [1]. The goal of prenatal karyotyping is to obtain fetal genetic material through the most efficient and least invasive means possible. **Why Fetal Skin Biopsy is the Correct Answer:** While a fetal skin biopsy contains fetal cells, it is **not** a routine or standard procedure for karyotyping. It is an invasive surgical procedure that carries a high risk of trauma, scarring, and infection to the fetus. Historically, it was used for diagnosing rare genodermatoses (like Ichthyosis), but for chromosomal analysis, it has been entirely superseded by safer, less invasive liquid-based or tissue-based sampling methods. **Analysis of Other Options:** * **Amniocentesis:** The "gold standard" and most common method. It involves aspirating amniotic fluid containing desquamated fetal cells (amniocytes) usually between 15–20 weeks of gestation. * **Chorionic Villus Sampling (CVS):** Performed earlier (10–13 weeks), it involves sampling placental tissue. It provides a high yield of rapidly dividing cells, allowing for faster results. * **Cordocentesis (Percutaneous Umbilical Blood Sampling):** Involves collecting fetal blood directly from the umbilical vein. It is used after 18 weeks for rapid karyotyping (results in 48–72 hours) when other tests are inconclusive. **High-Yield Clinical Pearls for NEET-PG:** * **Timing is Key:** CVS (10–13 weeks) → Amniocentesis (15–20 weeks) → Cordocentesis (>18 weeks). * **Cell Stimulant:** Phytohemagglutinin (PHA) is used in the lab to stimulate T-lymphocyte mitosis for karyotyping. * **Arrest Phase:** Colchicine is added to arrest cells in **Metaphase**, which is the best stage to visualize chromosome morphology [2]. * **Non-Invasive Prenatal Testing (NIPT):** Modern screening uses "cell-free fetal DNA" from maternal blood, but definitive karyotyping still requires the invasive methods mentioned above. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 167-168. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 54-55.
Explanation: **Explanation:** The demonstration of lipids (fats) in histopathology requires specific staining techniques because lipids are typically dissolved and lost during routine processing (dehydration with alcohols and clearing with xylene). To preserve fat, **frozen sections** [1] must be used instead of paraffin-embedded tissues. **Why "All of the above" is correct:** All three listed agents are standard methods for lipid visualization, though they work through different mechanisms: 1. **Oil Red O (Option A):** This is a lysochrome (fat-soluble dye). It works by being more soluble in the lipid droplets than in the solvent (isopropanol), thereby staining neutral lipids and cholesterols a brilliant **red**. 2. **Sudan Black B (Option B):** This is the most sensitive of the Sudan dyes. It stains neutral fats **black** and is frequently used in hematopathology to differentiate AML (Sudan Black positive) from ALL (Sudan Black negative). 3. **Osmium Tetroxide (Option C):** Unlike the others, this is a chemical fixative. It reacts with unsaturated lipids to form a black compound. It is unique because it **fixes and stains** fat simultaneously, allowing the tissue to be processed for electron microscopy. **High-Yield Clinical Pearls for NEET-PG:** * **Frozen Section:** Essential for fat staining (except when using Osmium Tetroxide) [1]. * **Sudan IV:** Another common stain that colors fat orange-red. * **Nile Blue Sulfate:** Used to differentiate between neutral fats (pink/red) and acidic lipids like phospholipids (blue). * **Clinical Application:** These stains are vital for diagnosing **Fat Embolism Syndrome** (demonstrating fat globules in lung or kidney capillaries) and **Non-Alcoholic Fatty Liver Disease (NAFLD)** [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 25-26. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 848.
Explanation: **Explanation:** The correct answer is **Multiple Sclerosis (MS)**. Autoimmune diseases are broadly classified into those mediated by antibodies (Type II or III hypersensitivity) and those mediated by T cells (Type IV hypersensitivity) [1]. **Why Multiple Sclerosis is correct:** Multiple Sclerosis is a classic example of a **Type IV hypersensitivity reaction** [1]. It is primarily mediated by **TH1 and TH17 cells**, which react against myelin self-antigens (like myelin basic protein) [2]. These T cells cross the blood-brain barrier and secrete cytokines (IFN-γ, IL-17) that recruit macrophages and activate B cells, leading to the characteristic demyelination of the central nervous system [2]. **Analysis of Incorrect Options:** * **A. Myasthenia Gravis:** This is a **Type II hypersensitivity** reaction. It is mediated by autoantibodies against the post-synaptic acetylcholine receptors (AChR) at the neuromuscular junction. * **B. Autoimmune Atrophic Gastritis:** While T cells play a role in the initial destruction of parietal cells, the clinical hallmark and diagnostic markers are **antibodies** against parietal cells and intrinsic factor (Type II hypersensitivity). * **C. Systemic Lupus Erythematosus (SLE):** SLE is the prototype of **Type III hypersensitivity**. It is characterized by the formation of immune complexes (antigen-antibody complexes) that deposit in various tissues, causing systemic inflammation. **NEET-PG High-Yield Pearls:** * **T-cell mediated diseases (Type IV):** Type 1 Diabetes Mellitus, Rheumatoid Arthritis, Multiple Sclerosis [3], Inflammatory Bowel Disease, and Psoriasis. * **Antibody-mediated (Type II):** Graves’ disease, Myasthenia gravis, Goodpasture syndrome, and Pernicious anemia. * **Key Cytokines in MS:** IFN-γ (from TH1) activates macrophages; IL-17 (from TH17) promotes leukocyte recruitment [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 216-218. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, p. 1286. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 221-222.
Explanation: **Explanation:** **Reiter’s Disease (Reactive Arthritis)** is the correct answer because it is statistically the most common autoimmune-mediated inflammatory arthropathy affecting young men (typically aged 20–40) [1]. It classically follows a gastrointestinal (e.g., *Salmonella*, *Shigella*) or genitourinary (e.g., *Chlamydia trachomatis*) infection [1]. The strong male predominance (up to 9:1 in venereal cases) and its prevalence in early adulthood make it the most frequent choice in this demographic. **Analysis of Options:** * **Ankylosing Spondylitis (AS):** While AS also affects young men and is strongly associated with HLA-B27, it is a chronic, progressive spondyloarthropathy [1]. Reactive arthritis occurs more frequently in the general population as an acute/subacute autoimmune response to common triggers. * **Inclusion Body Myositis (IBM):** This is an inflammatory myopathy that characteristically affects **older adults** (typically >50 years) and is more common in men, but it is rare in the "young man" demographic. * **CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy):** This is a neurological autoimmune condition. While it can affect any age, it is far less common than inflammatory arthritis. **NEET-PG High-Yield Pearls:** * **The Classic Triad:** "Can't see, can't pee, can't climb a tree" (Conjunctivitis, Urethritis, and Arthritis) [1]. * **Genetic Association:** Strongly linked to **HLA-B27** (present in ~75% of cases) [1]. * **Cutaneous Manifestations:** Look for **Keratoderma blennorrhagicum** (psoriasis-like skin lesions on palms/soles) and **Circinate balanitis**. * **Joint Involvement:** Typically presents as an asymmetric oligoarthritis affecting the lower limbs [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 680-681.
Explanation: **Explanation:** The clinical presentation of fatigue, fever, anorexia, and weight loss constitutes a cluster of **constitutional symptoms** often referred to as "B-symptoms" in hematological oncology [1][3]. **1. Why Leukemia is Correct:** Leukemia, particularly acute forms (AML/ALL), presents with these systemic features due to two primary mechanisms: * **Hypermetabolic State:** Rapidly dividing neoplastic cells consume significant energy and nutrients, leading to weight loss and anorexia [3]. * **Cytokine Release:** Neoplastic cells release pyrogens (like IL-1, IL-6, and TNF-α), which act on the hypothalamus to cause fever. * **Bone Marrow Failure:** Fatigue is a direct result of anemia caused by the replacement of normal marrow by leukemic blasts (myelophthisis) [4]. **2. Why Other Options are Incorrect:** * **Scurvy (Vitamin C deficiency):** Typically presents with gingival bleeding, perifollicular hemorrhages, and "corkscrew" hairs. While fatigue occurs, significant weight loss and high fever are not hallmark features. * **AIDS:** While it causes weight loss (wasting syndrome) and fever, it is a secondary immunodeficiency. In the context of pathology exams, if "Leukemia" is an option alongside these systemic symptoms, it is the preferred "primary" neoplastic diagnosis unless HIV-specific risk factors are mentioned. * **Sarcoidosis:** A multisystem granulomatous disease. While it can cause fatigue and weight loss, it most characteristically presents with bilateral hilar lymphadenopathy and respiratory symptoms (dyspnea, cough). **NEET-PG High-Yield Pearls:** * **B-Symptoms:** Fever (>38°C), drenching night sweats, and weight loss (>10% in 6 months). These are crucial for staging lymphomas (Ann Arbor Staging) [1]. * **Pancytopenia:** Always consider leukemia in a patient with constitutional symptoms and signs of marrow failure (bleeding, infections, anemia) [2][4]. * **TNF-α:** Also known as "Cachectin," it is the primary cytokine responsible for the anorexia and weight loss seen in malignancy [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 612-613. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 621-622. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 235-236. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 576-577.
Explanation: ### Explanation **Dyskeratosis** is a pathological term used to describe **premature keratinization** of individual cells within the epidermis, specifically occurring below the *stratum granulosum* (where keratinization normally begins) [1]. In these cells, the cytoplasm becomes intensely eosinophilic (pink) and the nucleus becomes pyknotic, representing a derangement in the normal maturation process of squamous epithelium [1]. #### Why the Correct Answer is Right: * **Premature Keratinization:** Dyskeratosis occurs when cells produce keratin prematurely or abnormally. It is a hallmark of both benign conditions (e.g., **Darier’s disease**, where "corps ronds" and "grains" are seen) and malignant/premalignant conditions (e.g., **Squamous Cell Carcinoma** and **Actinic Keratosis**) [1], [2]. #### Why Other Options are Wrong: * **Leukoplakia:** This is a clinical term, not a histological one [3]. It refers to a white patch or plaque on the mucosa that cannot be rubbed off [3]. While dyskeratosis may be seen *within* a biopsy of leukoplakia, the terms are not synonymous. * **Hyperpigmentation:** This refers to an increase in melanin deposition (melanosis) or an increase in the number of melanocytes, unrelated to the keratinization process. * **Nail Dystrophy:** This is a general clinical term for malformation or degeneration of the nails, which can be caused by various factors (fungal infections, psoriasis, or lichen planus), but it does not define the cellular process of dyskeratosis. #### High-Yield Clinical Pearls for NEET-PG: * **Malignant Dyskeratosis:** Characterized by "Keratin Pearls" or "Horn Pearls," which are pathognomonic for well-differentiated **Squamous Cell Carcinoma (SCC)**. * **Benign Dyskeratosis:** Classically seen in **Darier’s disease** (autosomal dominant) due to a mutation in the *ATP2A2* gene. * **Distinction:** Do not confuse *Dyskeratosis* (abnormal keratinization) with *Dysplasia* (disordered growth and loss of architectural orientation) [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Manifestations Of Central And Peripheral Nervous System Disease, pp. 742-743. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Skin, p. 1156. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, p. 1000.
Explanation: **Explanation:** The formation of an **epithelioid granuloma** is a hallmark of **Type IV (delayed-type) hypersensitivity** [3], where activated macrophages transform into epithelioid cells (cells with abundant pink cytoplasm and slipper-shaped nuclei) to sequester indigestible antigens [2], [4]. **Why Pneumocystis carinii (P. jirovecii) is the correct answer:** *Pneumocystis jirovecii* is an opportunistic fungus that typically causes interstitial pneumonia in immunocompromised patients (e.g., HIV/AIDS) [1]. Histologically, it is characterized by a **"foamy, cotton-candy" intra-alveolar exudate** containing the organisms, which are best visualized with Silver stains (GMS) [1]. It does **not** typically induce a granulomatous response because the host's cell-mediated immunity is usually too deficient to form organized granulomas. **Analysis of Incorrect Options:** * **Sarcoidosis:** Characterized by classic **non-caseating** epithelioid granulomas [4], [5]. High-yield findings include Schaumann bodies and Asteroid bodies. * **Tuberculosis:** The prototype of granulomatous inflammation, typically presenting with **caseating** (central necrosis) epithelioid granulomas. * **Hodgkin’s Lymphoma:** Epithelioid granulomas can be found within the involved lymph nodes or even in the bone marrow/liver of these patients. This is considered a host immune reaction to the tumor cells. **NEET-PG High-Yield Pearls:** 1. **Epithelioid cells** are activated macrophages modified by **IFN-gamma** (secreted by Th1 cells) [2]. 2. **Non-caseating granulomas** are also seen in Crohn’s disease, Lepromatous leprosy (rarely), and Cat-scratch disease (stellate granulomas). 3. **Pneumocystis** diagnosis: Look for "crushed ping-pong ball" appearance on GMS stain [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 318-319. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 109. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 173-174. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 198-200. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 700-701.
Explanation: **Explanation:** Angiogenesis (neovascularization) is a critical process in wound healing, chronic inflammation, and tumor growth [1]. It is tightly regulated by a balance between pro-angiogenic and anti-angiogenic factors [1]. **Why IFN is the correct answer:** **Interferons (specifically IFN-α and IFN-γ)** are potent **inhibitors** of angiogenesis. They function as angiostatic factors by suppressing the proliferation of endothelial cells and inhibiting the production of pro-angiogenic proteins like bFGF and VEGF. In clinical practice, IFN-α is sometimes used therapeutically to treat hemangiomas because of this inhibitory effect. **Why the other options are incorrect:** * **VEGF (Vascular Endothelial Growth Factor):** The most important and potent stimulator of angiogenesis [1]. It induces endothelial cell proliferation, migration, and increased vascular permeability [1]. * **PDGF (Platelet-Derived Growth Factor):** Plays a crucial role in the "maturation" phase of angiogenesis by recruiting pericytes and smooth muscle cells to stabilize the newly formed vessel wall [2]. * **TGF-β (Transforming Growth Factor-beta):** Acts as a dual regulator but is primarily considered pro-angiogenic in the context of the extracellular matrix [2]. It stimulates the synthesis of matrix proteins and helps in the stabilization of new vessels [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Most potent angiogenic factor:** VEGF [1]. * **Key driver of angiogenesis in tumors:** Hypoxia (via HIF-1α which triggers VEGF) [1]. * **Other Angiostatic factors (Inhibitors):** Angiostatin (fragment of plasminogen), Endostatin (fragment of Collagen XVIII), and Thrombospondin-1 [1]. * **FGF-2 (bFGF):** Another major angiogenic factor that promotes endothelial cell proliferation [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 313-314. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 115-119.
Cell Injury and Cell Death
Practice Questions
Adaptations of Cellular Growth
Practice Questions
Accumulations and Deposits
Practice Questions
Acute and Chronic Inflammation
Practice Questions
Tissue Repair and Wound Healing
Practice Questions
Hemodynamic Disorders
Practice Questions
Genetic Disorders
Practice Questions
Environmental Pathology
Practice Questions
Nutritional Diseases
Practice Questions
Molecular Basis of Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free